The trademark application LisinAmlo APONTIS was filed by Apontis Pharma Deutschland GmbH & Co. KG, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on July 17, 2023, and it was registered by office on October 24, 2023 without any oppositions.
The application was filed in German (English was selected as the second language).
Change of name and address of the trademark registration was recorded on July 11, 2024.